Registry number: ACTRN12624000905561

GenI-AIRSPACE is now actively recruiting across Australia with an aim to provide better treatment options for favourable intermediate risk prostate cancer patients. Professor Niall Corcoran and Professor Christopher Hovens from the University of Melbourne are running the world’s first randomised clinical trial using genomic testing and predictive disease modelling to reduce the burden of prostate cancer and avoid overtreatment. If this interests you, find out more about us, our partners, and how you can participate as directed below or contact us to discuss further steps.